WebJul 2, 2024 · Magellan Diagnostics is recalling its LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests due to a significant risk of falsely low results. The FDA has identified this as a Class I recall because of significant concerns that the performance of the test may provide falsely low results and may lead to health risks in special ... WebThe FDA Magellan Diagnostics Recall website includes the sentence “Customers should discontinue use of all test kit lots identified as part of the recall and quarantine remaining inventory.” The term “quarantine” means that labs should isolate any remaining “recalled” test kits. Non -recalled LeadCare®
Drug Recalls Magellan Rx Management
WebApr 5, 2024 · Magellan Diagnostics ultimately recalled all three devices in 2024 and resumed distribution last year, according to the FDA. The malfunction affected three of Magellan’s lead-testing devices,... WebJul 6, 2024 · The FDA notified CDC on June 24 that some Magellan Diagnostics blood lead test kits were undergoing a voluntary recall by the manufacturer. The FDA is now recommending that Magellan Diagnostics customers discontinue the use of all affected test kit lots identified as part of the recall and quarantine remaining inventory. gymnastics beat open gym
Ex-Magellan Diagnostics Execs Charged With Concealing Lead …
WebApr 5, 2024 · According to the Food and Drug Administration, Magellan Diagnostics issued a voluntary Class I recall, the most serious type, in May 2024 for several of its blood lead testing products... WebJul 6, 2024 · Magellan Diagnostics, Inc. is recalling its LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests due to a significant risk of falsely low blood lead … WebSep 28, 2024 · On August 31, 2024, Magellan Diagnostics, Inc., began customer notification of an expansion of its May 2024 recall of its LeadCare® Blood Lead … bozeman events today